Sir Peter Mansfield Magnetic Resonance Centre, School of Physics and Astronomy, University of Nottingham, Nottingham, UK.
NMR Biomed. 2013 Nov;26(11):1518-26. doi: 10.1002/nbm.2985. Epub 2013 Jul 9.
The measurement of tissue lipid and glycogen contents and the establishment of normal levels of variability are important when assessing changes caused by pathology or treatment. We measured hepatic and skeletal muscle lipid and glycogen levels using (1)H and (13)C MRS at 3 T in groups of subjects with and without type 2 diabetes. Within-visit reproducibility, due to repositioning and instrument errors was determined from repeat measurements made over 1 h. Natural variability was assessed from separate measurements made on three occasions over 1 month. Hepatic lipid content was greater in subjects with diabetes relative to healthy subjects (p = 0.03), whereas levels of hepatic and skeletal muscle glycogen, and of intra- and extra-myocellular lipid, were similar. The single-session reproducibility values (coefficient of variation, CV) for hepatic lipid content were 12% and 7% in groups of subjects with and without diabetes, respectively. The variability of hepatic lipid content over 1 month was greater than the reproducibility, with CV = 22% (p = 0.08) and CV = 44% (p = 0.004) in subjects with and without diabetes, respectively. Similarly, levels of variation in basal hepatic glycogen concentrations (subjects with diabetes, CV = 38%; healthy volunteers, CV = 35%) were significantly larger than single-session reproducibility values (CV = 17%, p = 0.02 and CV = 13%, p = 0.05, respectively), indicating substantial biological changes in basal concentrations over 1 month. There was a decreasing correlation in measurements of both hepatic lipid and glycogen content with increasing time between scans. Levels of variability in intra- and extra-myocellular lipid in the soleus muscle, and glycogen concentrations in the gastrocnemius muscle, tended to be larger than expected from single-session reproducibility, although these did not reach significance.
在评估病理或治疗引起的变化时,测量组织脂质和糖原含量并建立正常变异性水平非常重要。我们使用 3T 的 (1)H 和 (13)C MRS 在有和没有 2 型糖尿病的受试者组中测量肝和骨骼肌的脂质和糖原水平。由于重新定位和仪器误差,通过在 1 小时内重复测量来确定日内可重复性。从 1 个月内 3 次独立测量评估自然变异性。与健康受试者相比,糖尿病患者的肝脂质含量更高(p = 0.03),而肝和骨骼肌糖原以及细胞内和细胞外脂质水平相似。有和没有糖尿病的受试者组中单次测量的肝脂质含量的可重复性值(变异系数,CV)分别为 12%和 7%。1 个月内肝脂质含量的变异性大于可重复性,糖尿病患者的 CV = 22%(p = 0.08)和 CV = 44%(p = 0.004),而无糖尿病患者的 CV = 22%(p = 0.08)和 CV = 44%(p = 0.004)。同样,基础肝糖原浓度的变异水平(糖尿病患者,CV = 38%;健康志愿者,CV = 35%)明显大于单次测量的可重复性值(CV = 17%,p = 0.02 和 CV = 13%,p = 0.05),表明在 1 个月内基础浓度有实质性的生物学变化。肝脂质和糖原含量的测量值与两次扫描之间的时间呈负相关。比目鱼肌的细胞内和细胞外脂质以及腓肠肌的糖原浓度的变异性水平倾向于大于单次测量的可重复性,尽管这些没有达到显著水平。